Day One Biopharmaceuticals Inc. (DAWN) stock: comparing current and last year EPS estimates

The closing price of Day One Biopharmaceuticals Inc. (NASDAQ: DAWN) was $12.96 for the day, down -2.34% from the previous closing price of $13.27. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 865659 shares were traded. DAWN stock price reached its highest trading level at $13.91 during the session, while it also had its lowest trading level at $12.90.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



Our analysis of DAWN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.10 and its Current Ratio is at 14.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 when Bender Jeremy sold 3,104 shares for $13.12 per share. The transaction valued at 40,732 led to the insider holds 1,179,484 shares of the business.

York Charles N II sold 955 shares of DAWN for $12,532 on May 16. The COO, CFO and Secretary now owns 264,798 shares after completing the transaction at $13.12 per share. On May 16, another insider, Blackman Samuel C., who serves as the Chief Medical Officer of the company, sold 692 shares for $13.12 each. As a result, the insider received 9,081 and left with 1,235,592 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1.06B and an Enterprise Value of 723.35M.

Stock Price History:

Over the past 52 weeks, DAWN has reached a high of $28.35, while it has fallen to a 52-week low of $5.44. The 50-Day Moving Average of the stock is 13.92, while the 200-Day Moving Average is calculated to be 19.33.

Shares Statistics:

DAWN traded an average of 828.80K shares per day over the past three months and 778.45k shares per day over the past ten days. A total of 71.97M shares are outstanding, with a floating share count of 51.85M. Insiders hold about 14.90% of the company’s shares, while institutions hold 82.90% stake in the company. Shares short for DAWN as of Apr 27, 2023 were 9.12M with a Short Ratio of 9.12M, compared to 7.41M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 12.40% and a Short% of Float of 22.24%.

Earnings Estimates

The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.57 and a low estimate of -$0.66, while EPS last year was -$0.6. The consensus estimate for the next quarter is -$0.62, with high estimates of -$0.5 and low estimates of -$0.7.

Analysts are recommending an EPS of between -$2.05 and -$2.75 for the fiscal current year, implying an average EPS of -$2.48. EPS for the following year is -$2.05, with 10 analysts recommending between $0.65 and -$3.18.

Revenue Estimates

Based on 10 analysts’ estimates, the company’s revenue will be $63.37M in the next fiscal year. The high estimate is $255M and the low estimate is $6.8M. The average revenue growth estimate for next year is up 14,302.30% from the average revenue estimate for this year.